You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sickle nephropathy

Showing 26 - 50 of 1,786
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

VO2max & HRQoL in Children With Sickle Cell Disease

Completed
  • Sickle Cell
  • Children
    • Montpellier, Occitanie, France
      Pediatric and Congenital Cardiology Department, Arnaud De Villen
    Aug 16, 2023

    Assess Urine Biomarkers to Predict Nephropathy in Fabry Disease

    Recruiting
    • Fabry Disease
      • Rockville, Maryland
      • +1 more
      Sep 29, 2023

      Storage of Umbilical Cord Stem Cells for Treatment of Sickle

      Recruiting
      • Sickle Cell Disease
      • Sickle Cell Trait
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        Sickle Cell Disease Trial in Heidelberg

        Recruiting
        • Sickle Cell Disease
          • Heidelberg, BW, Germany
            Center for Child and Adolescent Medicine, University Medical Cen
          Nov 5, 2022

          Coronary Artery Disease, Chronic Kidney Diseases Trial in Chang chun, Shanghai (IVUS based ultralow contrast PCI)

          Not yet recruiting
          • Coronary Artery Disease
          • Chronic Kidney Diseases
          • IVUS based ultralow contrast PCI
          • Chang chun, Jilin, China
          • +1 more
          Jun 13, 2023

          Cardiovascular Diseases, Sickle Cell Disease, Exercise Trial in Birmingham (Exercise Treatment Group)

          Completed
          • Cardiovascular Diseases
          • +2 more
          • Exercise Treatment Group
          • Hollywood, Florida
            Memorial Healthcare System
          Dec 6, 2022

          IgA Nephropathy, Immunoglobulin A Nephropathy Trial (BION-1301, Placebo)

          Not yet recruiting
          • IgA Nephropathy
          • Immunoglobulin A Nephropathy
          • (no location specified)
          May 2, 2023

          Sickle Cell Disease, Sickle Cell Anemia, Osteonecrosis Trial (Alendronate Sodium)

          Not yet recruiting
          • Sickle Cell Disease
          • +4 more
          • Alendronate Sodium
          • (no location specified)
          Sep 6, 2023

          Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation

          Active, not recruiting
          • Diabetic Nephropathy
          • Grouping based on previous laboratory results, no intervention.
          • Jinan, Shandong, China
            Qianfoshan Hospital
          Nov 8, 2023

          Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of

          Active, not recruiting
          • Diabetic Nephropathy
          • Grouping based on previous laboratory results, no intervention.
          • Jinan, Shandong, China
            Qianfoshan Hospital
          Oct 24, 2023

          Secondary Pulmonary Hypertension in Sickle Cell Anemia

          Completed
          • Pulmonary Hypertension
          • +2 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jan 26, 2023

            Chronic Allograft Nephropathy Trial in Cairo (Elastography arm)

            Completed
            • Chronic Allograft Nephropathy
            • Elastography arm
            • Cairo, Egypt
              Cairo university hospitals
            Dec 27, 2022

            Glomerulonephritis, Membranous, Nephrotic Syndrome,Idiopathic Trial in Japan (Rituximab (genetical recombination), Placebo)

            Not yet recruiting
            • Glomerulonephritis, Membranous
            • Nephrotic Syndrome，Idiopathic
            • Rituximab (genetical recombination)
            • Placebo
            • Anjo, Aichi, Japan
            • +7 more
            Jun 13, 2023

            IgA Nephropathy Trial in Hangzhou (Telitacicept, Placebo)

            Not yet recruiting
            • IgA Nephropathy
            • Hangzhou, Zhejiang, China
              The Second Affiliated Hospital of Zhejiang University School of
            Oct 25, 2022

            Arterial Function Parameters and Transcranial Doppler Velocity

            Recruiting
            • Sickle Cell Disease
              • Kingston, Saint Andrew, Jamaica
                Caribbean Institute for Health Research, The University of the W
              Feb 17, 2023

              Membranous Nephropathy Trial in China (efgartigimod IV, )

              Recruiting
              • Membranous Nephropathy
              • efgartigimod IV
              • placebo
              • Changsha, China
              • +8 more
              Apr 11, 2023

              Idiopathic Membranous Nephropathy

              Not yet recruiting
              • Idiopathic Membranous Nephropathy
              • Obinutuzumab Injection
              • (no location specified)
              May 8, 2023

              Primary IgA Nephropathy Trial (SHR-2010 Injection, Placebo)

              Not yet recruiting
              • Primary IgA Nephropathy
              • SHR-2010 Injection
              • Placebo
              • (no location specified)
              Apr 27, 2023

              Sickle Cell Disease Trial in Atlanta, Cincinnati (I-STRONG for SCD)

              Recruiting
              • Sickle Cell Disease
              • I-STRONG for SCD
              • Atlanta, Georgia
              • +1 more
              Oct 26, 2023

              Sickle Cell Disease Trial in United States (Busulfan, Fludarabine, r-ATG)

              Active, not recruiting
              • Sickle Cell Disease
              • Oakland, California
              • +34 more
              Sep 21, 2022

              IgA Nephropathy Trial in China (Telitacicept, Placebo)

              Not yet recruiting
              • IgA Nephropathy
              • Telitacicept
              • Placebo
              • Hefei, Anhui, China
              • +79 more
              Mar 22, 2023

              Sickle Cell Hemoglobinopathies and Bone Health

              Active, not recruiting
              • Sickle Cell Disease
              • Sickle Cell Trait
              • Healthy volunteers without SCT
              • +2 more
              • Farmington, Connecticut
                UConn Health
              Nov 1, 2022

              Sickle Cell Disease Trial in Memphis (Plerixafor)

              Recruiting
              • Sickle Cell Disease
              • Memphis, Tennessee
                St. Jude Children's Research Hospital
              Jan 11, 2023

              Diabetic Kidney Disease Trial in Herlev (ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide,

              Recruiting
              • Diabetic Kidney Disease
              • ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide, baricitinib
              • Herlev, Denmark
                Department of Nephrology, Herlev and Gentofte Hospital
              May 31, 2023

              Diabetic Nephropathy Type 2 Trial (Acetylsalicylic Acid, Placebo)

              Not yet recruiting
              • Diabetic Nephropathy Type 2
              • Acetylsalicylic Acid
              • Placebo
              • (no location specified)
              Sep 28, 2023